33683704Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, SolĂ I, Santero M, Akdis CA, Akdis M, Canonica GW, Chivato T, Del Giacco S, Eiwegger T, Fokkens W, Georgalas C, Gevaert P, Hopkins C, Klimek L, Lund V, Naclerio R, O'Mahony L, Palkonen S, Pfaar O, Schwarze J, Soyka MB, Wang Y, Zhang L, Canelo-Aybar C, Palomares O, Jutel MAllergyBiological Products; Nasal Polyps; SinusitisAdult; Humans; Omalizumab; Quality of LifeEfficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy. 2021 08; 76(8):2337-2353.Allergy2021-03-24T00:00:002021Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000328Living Beings1578255770.254454AdultD001688Chemicals & Drugs781430.831438Biological ProductsD009298Disorders12570.927862Nasal PolypsD011788Concepts & Ideas43115750.549294Quality of LifeD006801Living Beings2262862810.130064HumansAuthorship 144859180.2028610.2028611authors10.257has subject areaD012852Disorders312090.817974SinusitisD000069444780.995862OmalizumabUniversity of ChicagoRobertNaclerioRobert M. Naclerio41.78927490000000-87.601250000000001970Naclerio, RobertEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, ProfessorSurgery-Ohns